Hyderabad (Telangana) [India], July 3 (ANI): Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per…
New York [US], July 2 (ANI): COVAX, the global alliance for vaccine distribution, on Thursday urged governments around the world to recognize as fully vaccinated all people who have received…
New Delhi [India], June 30 (ANI): India has requested EU member states to individually consider extending exemption to those persons who have taken Covishield and Covaxin and said it will…
New Delhi [India], June 30 (ANI): Hyderabad-based vaccine manufacturer Bharat Biotech on Wednesday said that the company hopes to start manufacturing its COVID-19 vaccine Covaxin in Bengaluru soon. "Bharat Biotech…
By Joymala Bagchi New Delhi [India], June 30 (ANI): Starting July 1, private hospitals in the country will no longer be allowed to directly procure COVID-19 vaccines from manufacturers and…
Hyderabad (Telangana) [India], June 30 (ANI): Issuing clarification on COVAXIN pricing controversy in Brazil, Bharat Biotech on Tuesday said it followed a step-by-step regulatory approval process during the eight-month period,…
Washington DC [US], June 30 (ANI): The National Institute of Health (NIH) in the United States has found that Bharat Biotech's COVAXIN vaccine generates antibodies that effectively neutralize both Alpha…
New Delhi [India], June 28 (ANI): In another significant COVID-19 vaccination milestone, India has overtaken the United States of America in the total number of vaccine doses administered so far,…
By Shalini Bhardwaj New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its…
By Shalini Bhardwaj And Sahil Pandey New Delhi [India], June 22 (ANI): The Subject Expert Committee (SEC) under the drug regulator will discuss reviewing the Phase III data of Bharat…
By Shalini Bhardwaj New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller…
By Shalini Bhardwaj New Delhi [India], June 17 (ANI): Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use…